Argenx
ARGX
#473
Rank
ยฃ37.36 B
Marketcap
ยฃ603.77
Share price
1.82%
Change (1 day)
10.17%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: ยฃ37.36 Billion

As of January 2026 Argenx has a market cap of ยฃ37.36 Billion. This makes Argenx the world's 473th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ37.36 B-4.37%
2025ยฃ39.07 B30.92%
2024ยฃ29.84 B68.48%
2023ยฃ17.71 B2.25%
2022ยฃ17.32 B27.16%
2021ยฃ13.62 B32.44%
2020ยฃ10.28 B96.11%
2019ยฃ5.24 B89.91%
2018ยฃ2.76 B86.2%
2017ยฃ1.48 B
2014ยฃ93.47 M

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Argenx was reported to be:

ยฃ36.82 Billion
by Nasdaq info icon info icon
ยฃ37.36 Billion
by CompaniesMarketCap info icon info icon